Why is KORU Medical Systems, Inc. ?
1
Poor long term growth as Operating profit has grown by an annual rate -220.07% of over the last 5 years
2
With a growth in Operating Profit of 101.18%, the company declared Very Positive results in Mar 26
- The company has declared positive results for the last 8 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 0.71 MM
- NET PROFIT(HY) Higher at USD -1.29 MM
- ROCE(HY) Highest at -13.7%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 20.00%, its profits have risen by 56.5%
4
High Institutional Holdings at 51.22%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
How much should you hold?
- Overall Portfolio exposure to KORU Medical Systems, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is KORU Medical Systems, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
KORU Medical Systems, Inc.
20.0%
1.36
52.85%
S&P 500
25.41%
1.92
13.25%
Quality key factors
Factor
Value
Sales Growth (5y)
11.21%
EBIT Growth (5y)
-220.07%
EBIT to Interest (avg)
-7.05
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.49
Sales to Capital Employed (avg)
1.79
Tax Ratio
0.05%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
51.22%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
12.33
EV to EBIT
-67.89
EV to EBITDA
-93.34
EV to Capital Employed
23.16
EV to Sales
4.91
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-34.11%
ROE (Latest)
-15.47%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
No Trend
Technical Movement
16What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 0.71 MM
NET PROFIT(HY)
Higher at USD -1.29 MM
ROCE(HY)
Highest at -13.7%
NET SALES(Q)
Highest at USD 11.76 MM
RAW MATERIAL COST(Y)
Fallen by 1.19% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 4.45 times
-3What is not working for the Company
CASH AND EQV(HY)
Lowest at USD 17.64 MM
PRE-TAX PROFIT(Q)
At USD -0.81 MM has Fallen at -23.4%
NET PROFIT(Q)
At USD -0.81 MM has Fallen at -22.38%
Here's what is working for KORU Medical Systems, Inc.
Operating Cash Flow
Highest at USD 0.71 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 11.76 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Inventory Turnover Ratio
Highest at 4.45 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by 1.19% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for KORU Medical Systems, Inc.
Pre-Tax Profit
At USD -0.81 MM has Fallen at -23.4%
over average net sales of the previous four periods of USD -0.65 MMMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -0.81 MM has Fallen at -22.38%
over average net sales of the previous four periods of USD -0.66 MMMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Cash and Eqv
Lowest at USD 17.64 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents






